Advertisement

AIDS Education pp 167-172 | Cite as

AIDS Education and the Prevention of Transfusion-Transmitted HIV Infection in the United States

  • S. Gerald Sandler

Abstract

Beginning in 1982—when AIDS was first suspected to be a blood-borne disease—and continuing until the present time, education for blood donors has been a principal public health strategy for preventing transfusion-transmitted HIV infections in the United States. Initially, the U. S. Public Health Service (USPHS) used epidemiological data obtained from studies of unusual opportunistic illnesses in male homosexuals, intravenous drug users and hemophiliacs to formulate preliminary surveillance definitions for “risk groups” for AIDS. These definitions were disseminated as educational messages via the Department of Health and Human Services (HHS), as well as by the USPHS Interagency AIDS Task Force, which included the Center for Disease Control (CDC), Food and Drug Administration (FDA), and National Institutes of Health (NIH). As the regulatory agency of the USPHS, the FDA disseminated regulatory communications about AIDS and transfusion-transmitted HIV infection for implementation by FDA-licensed blood collection sites. National organizations representing blood collectors, namely, the American Association of Blood Banks (AABB), American Red Cross (ARC), and the Council of Community Blood Centers (CCBC) promulgated these educational messages to constituent blood centers and blood banks. The following chapter presents a chronology of the development of these various education programs, their rationale, and their evolution as new scientific information became available. The unique interactions of the federal regulatory agency (FDA), the blood collection organizations (AABB, ARC, CCBC) and the public reflect norms of the American culture during the early years of the AIDS epidemic in the United States.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Acquire Immune Deficiency Syndrome Educational Message Acquire Immune Deficiency Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    CDC: Possible transfusion-associated acquired immune deficiency syndrome (AIDS)—California. MMWR 31:652–4, 1982Google Scholar
  2. 2.
    AABB-ARC-CCBC Joint Statement on AIDS: acquired immune deficiency syndrome related to transfusion. January 13, 1983Google Scholar
  3. 3.
    FDA: Recommendations to decrease the risk of transmitting acquired immune deficiency syndrome (AIDS) from blood donors. March 24, 1983Google Scholar
  4. 4.
    Sandler SG, Gerace NC: Management of the donation process, in Rossi EC, Simon TL, Moss GS (eds): Principles of Transfusion Medicine. Baltimore, MD, Williams & Wilkins, 1991, p 709.Google Scholar
  5. 5.
    Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP, Petersen LR: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 333:1721–5, 1995PubMedCrossRefGoogle Scholar
  6. 6.
    Weinstock HS, Sidher J, Gwinn M, Karon J, Peterson LR: Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988–92. J AIDS 9:514, 1995Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • S. Gerald Sandler
    • 1
  1. 1.Room M-1306, Clinical LaboratoriesGeorgetown University Medical CenterUSA

Personalised recommendations